Guangzhou Regenex Pharmaceutical Co., LTD (hereinafter referred to as Regenex Pharmaceutical or Regenex) is a high-tech pharmaceutical enterprise that specializes in developing, producing and selling pharmaceutical formulations for reproductive health, chronic diseases and other external preparations.
Established in 2003, Regenex is located in China’s famous high-tech industrial zone-Guangzhou Science City. With an area of 26,362 square meters, Regenex has a staff of 500, including more than 250 employees in marketing and 60 employees in R&D center.
For products, Levonorgestrel enteric-coated tablets (oral contraceptives) and condoms branded as “ZIOXX” are the most famous. “ZIOXX” condom series have received fund support from Bill & Melinda Gates Foundation.
For R&D, Regenex has parternerships with many institutions and Universities globally.
For marketing, Regenex sticks to the concept of “customer first “.For after-sales, Regenex implements 24 hours’ high-quality services. So far, Regenex has established cooperative relationship with distributors and spread its sales network all over our nation and also some European and American areas.
Adhering to the mission of “make human reproductive healthier” and fulfilling the culture of Value, High Efficiency and Pleasure, Regenex advocates the idea that the individual value can be fulfilled when realizing the enterprise value and customer value. In future, Regenex will continuously develop high-tech products and expand its business sector to make a high-speed development.